Skip to content
Biodatica
Start free

MUCOMMUNE, LLC

Morrisville, NC

OncologyCAR-TGrant-only
Compare Sign in to watch

What changed

Study registered, no phase assigned: Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis

5mo agoTrial registeredJan 29, 2026Source filing (opens the source filing in a new tab)

Momentum

60no change

Momentum 60 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    Study registered

    Nov 1, 2025

    Non-Small Cell Lung Cancer, Brain Metastases · ENROLLING_BY_INVITATION · sponsor: Ming Yang · Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis

    ClinicalTrials.gov · NCT07373951 (opens the source filing in a new tab)

  2. Grant

    R44 · $1.1M · non-dilutive

    Sep 16, 2025

    MUCOMMUNE, LLC · PI YANG, MING · NCI · award ends Aug 31, 2027 · SBIR: In vivo engineering of multifaceted B7H3.CAR-T cells for cellular immunotherapy of pancreatic ductal adenocarcinoma

    NIH RePORTER · NIH RePORTER 11316117 (opens the source filing in a new tab)

  3. Grant

    R44 · $1.0M · non-dilutive

    Sep 11, 2025

    MUCOMMUNE, LLC · PI YANG, MING · NCI · award ends Aug 31, 2027 · SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy

    NIH RePORTER · NIH RePORTER 11256191 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources